Abstract: The present invention relates to a substantially purified heparanase obtained from the human SK-HEP-1 cell line and a method to purify the heparanase from a centrifuged dialyzed homogenate of the SK-HEP-1 cells or a cell culture medium containing the heparanase from the SK-HEP-1 cell line.
Type:
Grant
Filed:
January 8, 1992
Date of Patent:
November 8, 1994
Assignee:
Hadassah Medical Organization Kiryat Hadassah